Register an account to search through 14,000+ stocks! 

OCUL – Ocular Therapeutix Inc

✔ COMPLIANT

★☆☆

Company Profile

Ocular Therapeutix, Inc. is a biopharmaceutical company, which is focused on the formulation, development and commercialization of therapies for diseases and conditions of the eye using its proprietary, bioresorbable hydrogel platform technology. The Company’s product pipeline candidates provide differentiated drug delivery solutions. The Company’s products include dexamethasone insert (DEXTENZA) and ReSure Sealant. Its DEXTENZA is an intracanalicular insert for the treatment of post-surgical ocular inflammation and pain. Its ReSure Sealant is an ophthalmic device designed to prevent wound leaks in corneal incisions following cataract surgery. The Company’s products that are in pipeline include OTX-TKI for the treatment of wet AMD, OTX-TIC for the treatment of glaucoma and ocular hypertension, OTX-CSI for the chronic treatment of dry eye disease, and OTX-DED for the short-term treatment of the signs and symptoms of dry eye disease.

Business

PASS

Ocular Therapeutix Inc has cleared the Business screen. Its business activity is compliant with the Shariah standard. If you find this result mistaken or questionable, let us know in the comments.

Problematic Revenues N/A
Interest Income
N/A
Total N/A

Fundamentals

Market cap $533972766
Assets
$261863000
ROA
-55.9
Div./Share
$-1.51

Financials

PASS

The financials pass just one standard and fail in the other two.

Debt/A Cash/A (AR+C)/A
18.92%
87.09%
87.09%
< 33%
< 33%
< 50%
P
F
F
Debt/MC Cash/MC
9.28%
42.71%
< 30%
< 30%
P
F
Debt/24MC Cash/24MC AR/24MC
6.63%
87.09%
N/A
< 33%
< 33%
< 33%
P
P

Note: A = Assets | AR = Accounts Receivables | MC = Market cap | 24MC = 24 month avg. Market cap

✘ FTSE ✘ AAOIFI ✔ DJIM

We do our best to screen stocks as accurately as possible. Please let us know in the comments if you spot an error or find something questionable. Jazaak Allahu khairan

Responses